Clinical trials
Completed Phase 1/2 Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 2 |
| Bio-Strath AG | 1 |
| Columbia University | 1 |
| Empros Pharma AB | 1 |
| Fundacion IMIM | 1 |
| Gan and Lee Pharmaceuticals, USA | 1 |
| Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Immunwork, Inc. | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 27 |
| Obesity | 18 |
| Diabetes Mellitus | 3 |
| Hypertension | 3 |
| Prediabetic State | 2 |
| Body Weight | 1 |
| Coronary Artery Disease | 1 |
| Dengue | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Glucose Intolerance | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.